DiaMedica Therapeutics Inc.DMAC

Market cap

$356.36M

P/E ratio

	Dec 31, 2018	Dec 31, 2019	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024
Cash and cash equivalents	-	4	7	5	5	5	3
Marketable securities	-	4	20	40	29	48	41
Amounts receivable	1	1	0	0	0	0	0
Prepaid expenses and other assets	-	0	0	0	0	0	0
Total current assets	18	9	28	45	34	54	45
Deposits	0	-	-	-	-	-	1
Operating lease right-of-use asset	-	0	0	0	0	0	0
Property and equipment, net	0	0	0	0	0	0	0
Total non-current assets	0	0	0	0	1	0	2
Total assets	18	9	28	46	34	54	46
Accounts payable	-	0	1	1	1	1	1
Accrued liabilities	-	1	1	1	1	2	4
Finance lease obligation	-	0	0	0	0	0	0
Operating lease obligation	-	0	0	0	0	0	0
Total current liabilities	1	1	2	2	2	3	5
Finance lease obligation, non-current	-	0	0	0	0	0	0
Operating lease obligation, non-current	-	0	0	-	0	0	0
Total non-current liabilities	0	0	0	0	0	0	0
Common shares, no par value; unlimited authorized; 42,818,660 and 37,958,000 shares issued and outstanding, as of December 31, 2024 and 2023, respectively	-	-	-	-	-	-	-
Paid-in capital	63	64	95	127	128	167	181
Accumulated other comprehensive income	-	0	-0	-0	-0	0	0
Accumulated deficit	-46	-57	-69	-82	-96	-116	-140
Total shareholders’ equity	17	8	26	44	32	51	41
Total liabilities and shareholders’ equity	18	9	28	46	34	54	46